Skip to main content
ELOX
NASDAQ Life Sciences

FDA Clears Eloxx IND for Exaluren in ADPKD; First Dosing Set for 3Q 2027

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.32
Mkt Cap
$52.958M
52W Low
$0.023
52W High
$23.4
52W Position
Off High info
43% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ELOX filed a Product Development and Regulatory on light trading volume (0.3× avg).

Summary

The FDA cleared Eloxx's IND for exaluren in nonsense-mutation ADPKD, letting the company move into the clinic with a 60-patient randomized study. First dosing is targeted for 3Q 2027, with topline data in 1H 2029 — a long runway before any readout. For a micro-cap biotech that posted an $8.3 million first-half loss and ended June with $62 million, this is a genuine pipeline expansion beyond its core programs, but the cash burn has to carry the company for roughly two and a half years before the first patient is even dosed. The 2029 data timeline means no near-term clinical catalyst; the next hard checkpoints are quarterly cash burn and any financing needed to fund the trial.

At the time of this announcement, ELOX was trading at $13.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53M. The 52-week trading range was $0.02 to $23.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ELOX - Latest Insights

ELOX
Aug 12, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $13.15 info
Change: -$6.03 (-31%) info
Market Cap: $53.079M info
ELOX
Aug 11, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $13.15 info
Change: -$6.03 (-31%) info
Market Cap: $53.079M info
ELOX
Aug 11, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $13.15 info
Change: -$6.03 (-31%) info
Market Cap: $53.079M info
ELOX
Jun 17, 2026, 5:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $13.15 info
Change: +$1.15 (+10%) info
Market Cap: $53.079M info
ELOX
Jun 04, 2026, 5:17 PM EDT
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.370
Real-time Price: $13.15 info
Change: +$12.78 (+3,454%) info
Market Cap: $53.079M info